Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4

Go back to Lexaria Releases Additional Results from its Successful Phase 1b Study GLP-1-H24-4
(NASDAQ: LEXX) Delayed: 0.54 --0 (-0%)
Previous Close $0.54    52 Week High
Open $0.54    52 Week Low
Day High $0.54    P/E N/A 
Day Low $0.54    EPS
Volume 72       

(NASDAQ: LEXXW) Delayed: 0.00 --0 (-0%)
Previous Close $0.00    52 Week High
Open $0.00    52 Week Low
Day High $0.00    P/E N/A 
Day Low $0.00    EPS
Volume 319